Good news for adults battling a specific type of blood cancer: on June 18, 2025, the FDA gave its stamp of approval to tafasitamab-cxix, known commercially as Monjuvi (Incyte/MorphoSys), to be ...

The FDA has accepted Aquestive Therapeutics’ new drug application for its Anaphylm sublingual epinephrine film for treating ...

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...

Wildtype’s salmon is not the first lab-grown food to receive the FDA’s stamp of approval—that honor went to two companies’ cultured chicken in 2022—but this does mark the first time a ...

RFK Jr. announces plan to legalize psychedelic therapy for veterans within 12 months, citing MDMA and ibogaine’s success in ...

Kennedy said that removing all 17 members of the CDC's vaccine advisory panel was "necessary to reestablish public confidence ...

A Seattle infectious disease doctor, whose work was pivotal early in the COVID pandemic, shares more on her experience with ...

FDA updates CAR T-cell therapy labels, easing monitoring requirements and expanding access for eligible patients in oncology.

Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS.

The FDA has approved its requested updated versions of expanded warning labels for COVID-19 vaccines. As Healio previously ...

Although Tissium first demonstrated its polymer material as a cardiovascular sealant, the application that the FDA just ...